EXHIBIT 107
CALCULATION OF FILING FEE TABLES
Form S-8
(Form Type)
Stoke Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1 – Newly Registered Securities
| Security Type | Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee | |||||||
| Equity | Common stock, par value $0.0001 per share | Other | 2,000,000(2) | $11.59(3) | $23,170,000 | $0.0001531 | $3,548 | |||||||
| Total Offering Amounts | $23,170,000 | $3,548 | ||||||||||||
| Total Fee Offsets | — | |||||||||||||
| Net Fee Due | $3,548 | |||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock, par value $0.0001 per share (“Common Stock”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of Common Stock. |
| (2) | Represents additional shares of Common Stock reserved for issuance upon the exercise of stock options and the settlement of restricted stock unit awards under the Registrant’s Amended and Restated 2023 Inducement Plan to certain employees as a material inducement to their acceptance of employment with the Registrant in accordance with Nasdaq Listing Rule 5635(c)(4). |
| (3) | Estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $11.59, the average of the high and low prices of the Registrant’s Common Stock as reported on The Nasdaq Global Select Market on July 2, 2025. |